[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Peptide Therapeutics Industry Research Report 2024

April 2024 | 124 pages | ID: PC6979559758EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

According to APO Research, The global Peptide Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics.

The Peptide Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • AbbVie
  • Ipsen
  • Ferring
  • Merck
  • The Medicines
  • J & J
Peptide Therapeutics segment by Type
  • Injection
  • Oral
  • Other
Peptide Therapeutics Segment by Application
  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other
Peptide Therapeutics Segment by Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Peptide Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Peptide Therapeutics by Type
  2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
  2.2.2 Injection
  2.2.3 Oral
  2.2.4 Other
2.3 Peptide Therapeutics by Application
  2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
  2.3.2 Cancer
  2.3.3 Metabolic Disorders
  2.3.4 Central Nervous System
  2.3.5 Other
2.4 Assumptions and Limitations

3 PEPTIDE THERAPEUTICS BREAKDOWN DATA BY TYPE

3.1 Global Peptide Therapeutics Historic Market Size by Type (2019-2024)
3.2 Global Peptide Therapeutics Forecasted Market Size by Type (2025-2030)

4 PEPTIDE THERAPEUTICS BREAKDOWN DATA BY APPLICATION

4.1 Global Peptide Therapeutics Historic Market Size by Application (2019-2024)
4.2 Global Peptide Therapeutics Forecasted Market Size by Application (2019-2024)

5 GLOBAL GROWTH TRENDS

5.1 Global Peptide Therapeutics Market Perspective (2019-2030)
5.2 Global Peptide Therapeutics Growth Trends by Region
  5.2.1 Global Peptide Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
  5.2.2 Peptide Therapeutics Historic Market Size by Region (2019-2024)
  5.2.3 Peptide Therapeutics Forecasted Market Size by Region (2025-2030)
5.3 Peptide Therapeutics Market Dynamics
  5.3.1 Peptide Therapeutics Industry Trends
  5.3.2 Peptide Therapeutics Market Drivers
  5.3.3 Peptide Therapeutics Market Challenges
  5.3.4 Peptide Therapeutics Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Peptide Therapeutics Players by Revenue
  6.1.1 Global Top Peptide Therapeutics Players by Revenue (2019-2024)
  6.1.2 Global Peptide Therapeutics Revenue Market Share by Players (2019-2024)
6.2 Global Peptide Therapeutics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Peptide Therapeutics Head office and Area Served
6.4 Global Peptide Therapeutics Players, Product Type & Application
6.5 Global Peptide Therapeutics Players, Date of Enter into This Industry
6.6 Global Peptide Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Peptide Therapeutics Market Size (2019-2030)
7.2 North America Peptide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Peptide Therapeutics Market Size by Country (2019-2024)
7.4 North America Peptide Therapeutics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Peptide Therapeutics Market Size (2019-2030)
8.2 Europe Peptide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Peptide Therapeutics Market Size by Country (2019-2024)
8.4 Europe Peptide Therapeutics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Peptide Therapeutics Market Size (2019-2030)
9.2 Asia-Pacific Peptide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Peptide Therapeutics Market Size by Country (2019-2024)
9.4 Asia-Pacific Peptide Therapeutics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia

10 LATIN AMERICA

10.1 Latin America Peptide Therapeutics Market Size (2019-2030)
10.2 Latin America Peptide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Peptide Therapeutics Market Size by Country (2019-2024)
10.4 Latin America Peptide Therapeutics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Peptide Therapeutics Market Size (2019-2030)
11.2 Middle East & Africa Peptide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Peptide Therapeutics Market Size by Country (2019-2024)
11.4 Middle East & Africa Peptide Therapeutics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE

12 PLAYERS PROFILED

12.1 Sanofi
  12.1.1 Sanofi Company Information
  12.1.2 Sanofi Business Overview
  12.1.3 Sanofi Revenue in Peptide Therapeutics Business (2019-2024)
  12.1.4 Sanofi Peptide Therapeutics Product Portfolio
  12.1.5 Sanofi Recent Developments
12.2 Teva
  12.2.1 Teva Company Information
  12.2.2 Teva Business Overview
  12.2.3 Teva Revenue in Peptide Therapeutics Business (2019-2024)
  12.2.4 Teva Peptide Therapeutics Product Portfolio
  12.2.5 Teva Recent Developments
12.3 Novo Nordisk
  12.3.1 Novo Nordisk Company Information
  12.3.2 Novo Nordisk Business Overview
  12.3.3 Novo Nordisk Revenue in Peptide Therapeutics Business (2019-2024)
  12.3.4 Novo Nordisk Peptide Therapeutics Product Portfolio
  12.3.5 Novo Nordisk Recent Developments
12.4 Takeda
  12.4.1 Takeda Company Information
  12.4.2 Takeda Business Overview
  12.4.3 Takeda Revenue in Peptide Therapeutics Business (2019-2024)
  12.4.4 Takeda Peptide Therapeutics Product Portfolio
  12.4.5 Takeda Recent Developments
12.5 Eli Lilly
  12.5.1 Eli Lilly Company Information
  12.5.2 Eli Lilly Business Overview
  12.5.3 Eli Lilly Revenue in Peptide Therapeutics Business (2019-2024)
  12.5.4 Eli Lilly Peptide Therapeutics Product Portfolio
  12.5.5 Eli Lilly Recent Developments
12.6 AstraZeneca
  12.6.1 AstraZeneca Company Information
  12.6.2 AstraZeneca Business Overview
  12.6.3 AstraZeneca Revenue in Peptide Therapeutics Business (2019-2024)
  12.6.4 AstraZeneca Peptide Therapeutics Product Portfolio
  12.6.5 AstraZeneca Recent Developments
12.7 Novartis
  12.7.1 Novartis Company Information
  12.7.2 Novartis Business Overview
  12.7.3 Novartis Revenue in Peptide Therapeutics Business (2019-2024)
  12.7.4 Novartis Peptide Therapeutics Product Portfolio
  12.7.5 Novartis Recent Developments
12.8 AbbVie
  12.8.1 AbbVie Company Information
  12.8.2 AbbVie Business Overview
  12.8.3 AbbVie Revenue in Peptide Therapeutics Business (2019-2024)
  12.8.4 AbbVie Peptide Therapeutics Product Portfolio
  12.8.5 AbbVie Recent Developments
12.9 Ipsen
  12.9.1 Ipsen Company Information
  12.9.2 Ipsen Business Overview
  12.9.3 Ipsen Revenue in Peptide Therapeutics Business (2019-2024)
  12.9.4 Ipsen Peptide Therapeutics Product Portfolio
  12.9.5 Ipsen Recent Developments
12.10 Ferring
  12.10.1 Ferring Company Information
  12.10.2 Ferring Business Overview
  12.10.3 Ferring Revenue in Peptide Therapeutics Business (2019-2024)
  12.10.4 Ferring Peptide Therapeutics Product Portfolio
  12.10.5 Ferring Recent Developments
12.11 Merck
  12.11.1 Merck Company Information
  12.11.2 Merck Business Overview
  12.11.3 Merck Revenue in Peptide Therapeutics Business (2019-2024)
  12.11.4 Merck Peptide Therapeutics Product Portfolio
  12.11.5 Merck Recent Developments
12.12 The Medicines
  12.12.1 The Medicines Company Information
  12.12.2 The Medicines Business Overview
  12.12.3 The Medicines Revenue in Peptide Therapeutics Business (2019-2024)
  12.12.4 The Medicines Peptide Therapeutics Product Portfolio
  12.12.5 The Medicines Recent Developments
12.13 J & J
  12.13.1 J & J Company Information
  12.13.2 J & J Business Overview
  12.13.3 J & J Revenue in Peptide Therapeutics Business (2019-2024)
  12.13.4 J & J Peptide Therapeutics Product Portfolio
  12.13.5 J & J Recent Developments

13 REPORT CONCLUSION

14 DISCLAIMER



More Publications